» Articles » PMID: 36410981

Preventative Options and the Future of Chemoprevention for Cutaneous Tumors

Overview
Journal Dermatol Clin
Specialty Dermatology
Date 2022 Nov 21
PMID 36410981
Authors
Affiliations
Soon will be listed here.
Abstract

Chemoprophylaxis against nonmelanoma skin cancer (NMSC) should be considered in high-risk populations such as those with certain genetic disorders, immunosuppressive states, chronic radiation, excessive UV exposure, or extensive personal or family history of NMSC. The methods for chemoprevention have progressed beyond traditional sunscreen into more effective strategies including DNA repair enzymes, nicotinamide, systemic retinoids, and nonsteroidal anti-inflammatory drugs. Other therapies are still being investigated and include treatments that target premalignant lesions, capecitabine, hedgehog inhibitors, difluoromethylornithine, metformin, and nutritional factors.

Citing Articles

Exploring chemoprevention strategies: mitigating skin cancer in high-risk individuals.

Roux J, Sharma A, Arora J, Cohen J Arch Dermatol Res. 2024; 316(7):446.

PMID: 38955838 DOI: 10.1007/s00403-024-03204-9.


Recent Advances in Clinical Research for Skin Cancer Chemoprevention.

Tow R, Hanoun S, Andresen B, Shahid A, Wang J, Kelly K Cancers (Basel). 2023; 15(15).

PMID: 37568635 PMC: 10417305. DOI: 10.3390/cancers15153819.